Insulet (PODD) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | -13.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.95% |
| Dec 31, 2025 | -22.74% |
| Sep 30, 2025 | 6.19% |
| Jun 30, 2025 | 24.71% |
| Mar 31, 2025 | 81.51% |
| Dec 31, 2024 | -20.04% |
| Sep 30, 2024 | 34.84% |
| Jun 30, 2024 | 54.53% |
| Mar 31, 2024 | 80.46% |
| Dec 31, 2023 | 488.47% |
| Sep 30, 2023 | 1,571.62% |
| Dec 31, 2019 | -30.33% |
| Sep 30, 2019 | 80.93% |
| Jun 30, 2019 | 67.63% |
| Dec 31, 2018 | 2,161.88% |
| Sep 30, 2018 | 130.68% |
| Jun 30, 2018 | 184.73% |
| Dec 31, 2017 | 85.74% |
| Sep 30, 2017 | -45.55% |
| Jun 30, 2017 | -69.99% |
| Mar 31, 2017 | 57.37% |
| Dec 31, 2016 | 79.93% |
| Sep 30, 2016 | 117.09% |
| Jun 30, 2016 | 90.56% |
| Mar 31, 2016 | -8.80% |
| Dec 31, 2015 | -1,154.81% |
| Sep 30, 2015 | -394.25% |
| Jun 30, 2015 | -228.60% |
| Mar 31, 2015 | -444.02% |
| Dec 31, 2014 | 683.56% |
| Sep 30, 2014 | 78.17% |
| Mar 31, 2014 | 70.52% |
| Dec 31, 2013 | 103.24% |
| Sep 30, 2013 | -101.82% |
| Mar 31, 2013 | 49.42% |
| Dec 31, 2012 | 46.86% |
| Sep 30, 2012 | 16.00% |
| Jun 30, 2012 | 18.03% |
| Mar 31, 2012 | -1.18% |
| Dec 31, 2011 | -224.16% |
| Sep 30, 2011 | -19.42% |
| Jun 30, 2011 | -27.46% |